Showing 1 - 11 results of 11 for search 'Thomas F Wierzba', query time: 0.04s
Refine Results
-
1
Oral cholera vaccines and their impact on the global burden of disease by Thomas F. Wierzba
Published 2019-06-01
Article -
2
Report on the International Symposium on Hepatitis E, Seoul, South Korea, 2010 by Thomas F. Wierzba, Ursula Panzner
Published 2012-05-01
Article -
3
Socio-ecological risk factors for prime-age adult death in two coastal areas of Vietnam. by Deok Ryun Kim, Mohammad Ali, Vu Dinh Thiem, Thomas F Wierzba
Published 2014-01-01
Article -
4
A Perspective on the Strategy for Advancing ETVAX<sup>®</sup>, An Anti-ETEC Diarrheal Disease Vaccine, into a Field Efficacy Trial in Gambian Children: Rationale, Challenges, Lesso... by M. Jahangir Hossain, Ann-Mari Svennerholm, Nils Carlin, Umberto D’Alessandro, Thomas F. Wierzba
Published 2023-12-01
Article -
5
Measles deaths in Nepal: estimating the national case-fatality ratio by Anand B Joshi, Elizabeth T Luman, Robin Nandy, Bal K Subedi, Jayantha BL Liyanage, Thomas F Wierzba
Published 2009-06-01
Article -
6
Whom and where are we not vaccinating? Coverage after the introduction of a new conjugate vaccine against group A meningococcus in Niger in 2010. by Sung Hye Kim, Lorenzo Pezzoli, Harouna Yacouba, Tiekoura Coulibaly, Mamoudou H Djingarey, William A Perea, Thomas F Wierzba
Published 2012-01-01
Article -
7
Effectiveness of the Viet Nam produced, mouse brain-derived, inactivated Japanese encephalitis vaccine in Northern Viet Nam. by Florian Marks, Thi Thu Yen Nguyen, Nhu Duong Tran, Minh Hong Nguyen, Hai Ha Vu, Christian G Meyer, Young Ae You, Frank Konings, Wei Liu, Thomas F Wierzba, Zhi-Yi Xu
Published 2012-01-01
Article -
8
A phase I trial of WRSS1, a Shigella sonnei live oral vaccine in Bangladeshi adults and children by Rubhana Raqib, Protim Sarker, K. Zaman, Nur Haque Alam, Thomas F. Wierzba, Nicole Maier, Kaisar Talukder, Abdullah Hel Baqui, Akamol E. Suvarnapunya, Firdausi Qadri, Richard I. Walker, Alan Fix, Malabi M. Venkatesan
Published 2019-06-01
Article -
9
Persistence of antibody responses to COVID-19 vaccines among participants in the COVID-19 Community Research Partnership by Andrea A. Berry, Ashley H. Tjaden, Jone Renteria, DeAnna Friedman-Klabanoff, Amy N. Hinkelman, Michael A. Gibbs, Amina Ahmed, Michael S. Runyon, John Schieffelin, Robert P. Santos, Richard Oberhelman, Matthew Bott, Adolfo Correa, Sharon L. Edelstein, Diane Uschner, Thomas F. Wierzba
Published 2023-12-01
Article -
10
Assessment of sociodemographic factors associated with time to self-reported COVID-19 infection among a large multi-center prospective cohort population in the southeastern United... by Andrew J Beron, Joshua O Yukich, Andrea A Berry, Adolfo Correa, Joseph Keating, Matthew Bott, Thomas F Wierzba, William S Weintraub, DeAnna J Friedman-Klabanoff, Morgana Mongraw-Chaffin, Michael A Gibbs, Yhenneko J Taylor, Patricia J Kissinger, Devin V Hayes, John S Schieffelin, Brian K Burke, Richard A Oberhelman
Published 2024-01-01
Article -
11
Could a Shigella vaccine impact long-term health outcomes?: Summary report of an expert meeting to inform a Shigella vaccine public health value proposition, March 24 and 29, 2021 by Karoun H. Bagamian, Chloe Puett, John D. Anderson, IV, Farzana Muhib, Clint Pecenka, Jere Behrman, Robert F. Breiman, Ijeoma Edoka, Susan Horton, Gagandeep Kang, Karen L. Kotloff, Claudio F. Lanata, James A. Platts-Mills, Firdausi Qadri, Elizabeth T. Rogawski McQuade, Christopher Sudfeld, Pascale Vonaesch, Thomas F. Wierzba, Suzanne Scheele
Published 2022-12-01
Article